Effective January 1, 2016, Egalet Corporation appointed Barbara Carlin as its Chief Accounting Officer. Since January 2014, Ms. Carlin, 41, has served as Vice President, Finance & Administration of the Company. Prior to joining the company, Ms. Carlin served as Director, Corporate Project Management of Topaz Pharmaceuticals Inc. from January 2011 to October 2011, as Finance Director of Swedish Orphan Biovitrum from February 2012 to August 2013 and as an independent financial consultant to various start-up life science companies from November 2011 to January 2012 and again from September 2013 to December 2013.

Prior to her time at Topaz, Ms. Carlin also held senior financial positions at Resources Global Professionals, Moksha8, Genaera Corporation, Vicuron Pharmaceuticals Inc. and Taylor and Francis, and as an auditor at Deloitte & Touche. Ms. Carlin is also a certified public accountant.